Paper Details

  1. Home
  2. Paper Details

Eletriptan for acute migraine.

Author: McQuayH J, MooreR A, OldmanA D, SmithL A

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Eletriptan (Relpax), a new type of migraine medication, will soon be available by prescription. There are currently five other similar medications available, and more are under development. With so many migraine treatments, evidence-based assessments are needed to compare their effectiveness and potential risks.
Paper Details　
Original Abstract of the Article :
Eletriptan (Relpax) is a new triptan soon to be made available by prescription for the treatment of acute migraine. Currently five triptans are available by prescription and more are under development. In light of the many drugs for treating acute migraine, there is a need for evidence-based assessm...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD003224

データ提供：米国国立医学図書館（NLM）

Eletriptan for Acute Migraine: A New Oasis in the Desert of Headache Relief

In the vast and often-painful desert of migraine treatment, the search for effective and safe therapies continues. This study introduces eletriptan (Relpax), a new triptan medication, as a potential treatment option for acute migraine attacks. The researchers discuss the need for evidence-based assessments to evaluate the relative efficacy and safety of eletriptan compared to other existing triptan medications.

Navigating the Desert of Migraine Treatment

This study represents a significant advancement in the quest for migraine relief, offering a new weapon in the fight against this debilitating condition. The researchers emphasize the importance of conducting rigorous clinical trials to compare the efficacy and safety of eletriptan to existing treatments.

A Beacon of Hope for Migraine Sufferers

This research offers a beacon of hope for migraine sufferers, promising a new avenue for managing this debilitating condition. The researchers' call for evidence-based assessments underscores the commitment to ensuring that patients receive the most effective and safe treatments available.

Dr. Camel's Conclusion

This research introduces eletriptan as a potential new treatment option for acute migraine, highlighting the need for further research to evaluate its efficacy and safety compared to existing therapies. The findings offer promise for individuals seeking relief from migraine pain and underscore the ongoing pursuit of effective and safe treatments for this challenging condition.
Date :
  1. Date Completed 2002-03-28
  2. Date Revised 2018-12-21
Further Info :

Pubmed ID

11687056

DOI: Digital Object Identifier

10.1002/14651858.CD003224

Related Literature

Article Analysis
・Effective treatment of migraine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.